MOLECULAR MECHANISMS OF MRNA STABILITY IN HUMAN SALIVA
人类唾液中 mRNA 稳定性的分子机制
基本信息
- 批准号:8360486
- 负责人:
- 金额:$ 21.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2012-09-04
- 项目状态:已结题
- 来源:
- 关键词:Biological MarkersCancer PatientCenters of Research ExcellenceDiseaseElementsFundingGene Expression RegulationGoalsGrantHumanKnowledgeMAP Kinase Activation PathwayMessenger RNAMolecularNational Center for Research ResourcesOral healthPathway interactionsPlayPrincipal InvestigatorProteinsRNARegulationResearchResearch InfrastructureResourcesRoleSalivaSourceSouth CarolinaUnited States National Institutes of HealthViralcostinsightmRNA DecaymRNA Stabilitymalignant mouth neoplasm
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Stabilization and destabilization of mRNA plays an important role in the regulation of gene expression. Our knowledge of presence of human mRNA and the stabilization that enables its presence in human saliva is very poor. The existence of viral, bacterial and human RNAs in saliva allows us to study the mechanisms and regulations of mRNA stability for various diseases. The challenges related to regulation of mRNA stability in human saliva, and how mRNA is stabilized by utilizing mRNA stability pathways is yet to uncover. We hypothesize that there are sequence elements and protein factors responsible for the differential presence of disease specific RNA biomarkers in saliva or oral cancer patients. This research will allow us to gain insights into the sequence elements and protein factors responsible for mRNA stability in human saliva. Therefore, the major goal of this proposal is to understand the mechanistic aspects of mRNA stability in human saliva. Two specific aims are proposed to accomplish these goals. I) Determine the fundamental mechanisms responsible for the stabilization of mRNA's in human saliva and II) Validate the AU-rich element containing mRNA decay in correlation with MAP kinase pathway activation.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。次级项目的主要支助
子项目的主要研究者可能是由其他来源提供的,
包括其它NIH来源。 为子项目列出的总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
mRNA的稳定和不稳定在基因表达调控中起着重要作用。 我们对人类mRNA的存在以及使其能够存在于人类唾液中的稳定性的了解非常少。唾液中病毒、细菌和人类RNA的存在使我们能够研究各种疾病的mRNA稳定性的机制和调控。 与人类唾液中mRNA稳定性的调节有关的挑战,以及如何通过利用mRNA稳定性途径来稳定mRNA尚未发现。我们假设,有序列元件和蛋白质因素负责唾液或口腔癌患者的疾病特异性RNA生物标志物的差异存在。这项研究将使我们能够深入了解负责人类唾液中mRNA稳定性的序列元件和蛋白质因子。因此,该提案的主要目标是了解人类唾液中mRNA稳定性的机制方面。为实现这些目标,提出了两个具体目标。I)确定负责人唾液中mRNA稳定化的基本机制,和II)研究与MAP激酶途径活化相关的含有富含AU的元件的mRNA衰变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Viswanathan Palanisamy其他文献
Viswanathan Palanisamy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Viswanathan Palanisamy', 18)}}的其他基金
Targeting of RNA-binding protein FXR1 in HNSCC
HNSCC 中 RNA 结合蛋白 FXR1 的靶向
- 批准号:
10571379 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别:
Comprehensive Identification of FXR1 Targets Using pSILAC-BONCAT Proteomics
使用 pSILAC-BONCAT 蛋白质组学全面鉴定 FXR1 靶标
- 批准号:
9241667 - 财政年份:2017
- 资助金额:
$ 21.1万 - 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
9237260 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
8657030 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
8993725 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
8503886 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
MOLECULAR MECHANISMS OF MRNA STABILITY IN HUMAN SALIVA
人类唾液中 mRNA 稳定性的分子机制
- 批准号:
8167773 - 财政年份:2010
- 资助金额:
$ 21.1万 - 项目类别:
Regulation of mRNA Stability in Human Saliva
人类唾液中 mRNA 稳定性的调节
- 批准号:
7769275 - 财政年份:2009
- 资助金额:
$ 21.1万 - 项目类别:
Regulation of mRNA Stability in Human Saliva
人类唾液中 mRNA 稳定性的调节
- 批准号:
8044130 - 财政年份:2009
- 资助金额:
$ 21.1万 - 项目类别:
Regulation of mRNA Stability in Human Saliva
人类唾液中 mRNA 稳定性的调节
- 批准号:
7879998 - 财政年份:2009
- 资助金额:
$ 21.1万 - 项目类别:
相似海外基金
Research Project 2 Proteogenomic-guided therapeutic targeting of breast cancer patient-derived xenograft metastases
研究项目 2 蛋白质基因组引导的乳腺癌患者异种移植转移的治疗靶向
- 批准号:
10733315 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别:
SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival
SQLE 和甾醇导致 ER 乳腺癌患者生存率的种族差异
- 批准号:
10571020 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别:
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
建立组件的工业化生产,使癌症患者群体能够更容易地获得 PET 成像。
- 批准号:
10698218 - 财政年份:2023
- 资助金额:
$ 21.1万 - 项目类别:
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
华盛顿大学 PDX 开发和试验中心 - Abemaciclib 联合 Olaparib 在卵巢癌和乳腺癌患者异种移植模型中的评估
- 批准号:
10582164 - 财政年份:2022
- 资助金额:
$ 21.1万 - 项目类别:
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10039823 - 财政年份:2022
- 资助金额:
$ 21.1万 - 项目类别:
EU-Funded
Convening a gynecologic cancer patient advisory group to adapt a digital health tool
召集妇科癌症患者咨询小组以采用数字健康工具
- 批准号:
460767 - 财政年份:2022
- 资助金额:
$ 21.1万 - 项目类别:
Miscellaneous Programs
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10038000 - 财政年份:2022
- 资助金额:
$ 21.1万 - 项目类别:
EU-Funded
Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patient
社会网络和情感状态作为癌症患者吸烟行为决定因素的纵向混合方法调查
- 批准号:
10513670 - 财政年份:2021
- 资助金额:
$ 21.1万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10598311 - 财政年份:2021
- 资助金额:
$ 21.1万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10442585 - 财政年份:2021
- 资助金额:
$ 21.1万 - 项目类别: